tiprankstipranks
Resmed (RMD)
NYSE:RMD
US Market

Resmed Financial Overview

Resmed's market cap is currently ―. The company's EPS TTM is $7.543; its P/E ratio is ―; and it has a dividend yield of 0.81%. Resmed is scheduled to report earnings on January 30, 2025, and the estimated EPS forecast is $2.32. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total Revenue
Gross Profit$ 2.66B$ 2.36B$ 2.02B$ 1.84B$ 1.72B
Operating Income$ 1.32B$ 1.13B$ 1.00B$ 903.68M$ 809.66M
EBITDA$ 1.48B$ 1.30B$ 1.20B$ 1.10B$ 990.43M
Net Income$ 1.02B$ 897.56M$ 779.44M$ 474.50M$ 621.67M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 6.87B$ 6.75B$ 5.10B$ 4.73B$ 4.59B
Total Debt$ 873.93M$ 1.58B$ 917.55M$ 793.72M$ 1.30B
Net Debt$ 635.57M$ 1.35B$ 643.84M$ 498.44M$ 836.11M
Total Liabilities$ 2.01B$ 2.62B$ 1.74B$ 1.84B$ 2.09B
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ 1.29B$ 559.30M$ 195.11M$ 619.89M$ 696.32M
Operating Cash Flow$ 1.40B$ 693.30M$ 351.15M$ 736.72M$ 802.26M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Resmed Earnings and Revenue History

Resmed Debt to Assets

Resmed Cash Flow

Resmed Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis